Filing Flows

Filing Flows › Boston Scientific (BSX) › Next earnings date

Boston Scientific (BSX) earnings

Boston Scientific (BSX) last reported on Oct 28, 2026: revenue $5.1B for the third quarter 2026. The next date is not set yet. It beat the EPS estimate in 100% of the quarters on record.

Beat rate100%

The last report

Boston Scientific reported revenue of $5.1B for the third quarter 2026 (+1% Y/Y), net earnings $580M: Interventional Cardiology & Vascular Therapies $1.3B, Electrophysiology $816M, Endoscopy $741M, Urology $661M. How it makes money → · Every quarter →

Boston Scientific: EPS against the estimate, last 5 reportsBoston Scientific: EPS against the estimate, last 5 reportsEstimateReported$0.71$0.75Oct 25$0.78$0.80Feb 26$0.79$0.80Apr 26$0.83$0.86Jul 26$0.72$0.73Oct 26
Latest (Oct 26): Estimate $0.72, Reported $0.73.
BSX: the stock's move on each reportBSX: the stock's move on each reportJul 29, 2026-0.1%Apr 22, 2026+10.4%Feb 4, 2026-15.3%Oct 22, 2025+2.5%

Boston Scientific's latest quarter

Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.

Questions

When does BSX report earnings?

The next date is not set yet.

Does Boston Scientific usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.